Identification of Dermcidin as a novel binding protein of Nck1 and characterization of its role in promoting cell migration

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 6, 2011, Pages 703-710

  Shen, Shun Li ^a   Qiu, Fang Hua ^a   Dayarathna, Thamara K ^c   Wu, Jian ^a   Kuang, Ming ^a   Li, Shawn S C ^c   Peng, Bao Gang ^a   Nie, Jing ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

Cell migration; Dermcidin; Hepatocellular carcinoma; Nck1; SH2 domain; Tyrosine phosphorylation

Indexed keywords

DERMCIDIN; NCK PROTEIN; PHOSPHOTYROSINE; PROTEIN CDC42; PROTEIN NCK1; PROTEIN SH2; RAC1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL MIGRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEOMICS; RHO GTP-BINDING PROTEINS; SRC HOMOLOGY DOMAINS; TYROSINE;

EID: 79954612462     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.03.004     Document Type: Article

References (28)

1. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
2. Zhou X.D. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat. Dis. Int. 2002, 1:35-41.
3. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
4. Yamaguchi H., Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 2007, 1773:642-652.
5. Bladt F., Aippersbach E., Gelkop S., Strasser G.A., Nash P., Tafuri A., Gertler F.B., Pawson T. The murine Nck SH2/SH3 adaptors are important for the development of mesoderm-derived embryonic structures and for regulating the cellular actin network. Mol. Cell. Biol. 2003, 23:4586-4597.
6. Miyamoto Y., Yamauchi J., Mizuno N., Itoh H. The adaptor protein Nck1 mediates endothelin A receptor-regulated cell migration through the Cdc42-dependent c-Jun N-terminal kinase pathway. J. Biol. Chem. 2004, 279:34336-34342.
7. Jones N., Blasutig I.M., Eremina V., Ruston J.M., Bladt F., Li H., Huang H., Larose L., Li S.S., Takano T., Quaggin S.E., Pawson T. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006, 440:818-823.
8. Li Z., Hannigan M., Mo Z., Liu B., Lu W., Wu Y., Smrcka A.V., Wu G., Li L., Liu M., Huang C.K., Wu D. Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell 2003, 114:215-227.
9. Zhao Z.S., Manser E., Lim L. Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation. Mol. Cell. Biol. 2000, 20:3906-3917.
10. Li W., Fan J., Woodley D.T. Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene 2001, 20:6403-6417.
11. Gossage L., Eisen T. Targeting multiple kinase pathways: a change in paradigm. Clin. Cancer Res. 2010, 16:1973-1978.
12. Wang X., Nie J., Zhou Q., Liu W., Zhu F., Chen W., Mao H., Luo N., Dong X., Yu X. Downregulation of Par-3 expression and disruption of Par complex integrity by TGF-beta during the process of epithelial to mesenchymal transition in rat proximal epithelial cells. Biochim. Biophys. Acta 2008, 1782:51-59.
13. Nie J., Wu Q., Liu W., Zhu F., Qiu F., Zhou Q., Fan J., Dong X., Yu X. Ectopic expression of Ligand-of-Numb protein X promoted TGF-beta induced epithelial to mesenchymal transition of proximal tubular epithelial cells. Biochim. Biophys. Acta 2009, 1792:122-131.
14. Porter D., Weremowicz S., Chin K., Seth P., Keshaviah A., Lahti-Domenici J., Bae Y.K., Monitto C.L., Merlos-Suarez A., Chan J., Hulette C.M., Richardson A., Morton C.C., Marks J., Duyao M., Hruban R., Gabrielson E., Gelman R., Polyak K. A neural survival factor is a candidate oncogene in breast cancer. Proc. Natl Acad. Sci. U.S.A. 2003, 100:10931-10936.
15. Hu T., Shi G., Larose L., Rivera G.M., Mayer B.J., Zhou R. Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1. Biochemistry 2009, 48:6369-6378.
16. Monitto C.L., Dong S.M., Jen J., Sidransky D. Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia. Clin. Cancer Res. 2004, 10:5862-5869.
17. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., Tisdale M. Characterization of a cancer cachectic factor. Nature 1996, 379:739-742.
18. Lowrie A.G., Wigmore S.J., Wright D.J., Waddell I.D., Ross J.A. Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues. Br. J. Cancer 2006, 94:1663-1671.
19. Watchorn T.M., Waddell I., Dowidar N., Ross J.A. Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3. FASEB J. 2001, 15:562-564.
20. Lee Motoyama J.P., Kim-Motoyama H., Kim P., Nakagama H., Miyagawa K., Suzuki K. Identification of dermcidin in human gestational tissue and characterization of its proteolytic activity. Biochem. Biophys. Res. Commun. 2007, 357:828-833.
21. Blasutig I.M., New L.A., Thanabalasuriar A., Dayarathna T.K., Goudreault M., Quaggin S.E., Li S.S., Gruenheid S., Jones N., Pawson T. Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization. Mol. Cell. Biol. 2008, 28:2035-2046.
22. Nishimura R., Li W., Kashishian A., Mondino A., Zhou M., Cooper J., Schlessinger J. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol. Cell. Biol. 1993, 13:6889-6896.
23. Buday L., Wunderlich L., Tamas P. The Nck family of adapter proteins: regulators of actin cytoskeleton. Cell. Signal. 2002, 14:723-731.
24. Ostman A., Hellberg C., Bohmer F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 2006, 6:307-320.
25. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
26. Liu B.A., Jablonowski K., Raina M., Arce M., Pawson T., Nash P.D. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol. Cell 2006, 22:851-868.
27. Machida K., Thompson C.M., Dierck K., Jablonowski K., Karkkainen S., Liu B., Zhang H., Nash P.D., Newman D.K., Nollau P., Pawson T., Renkema G.H., Saksela K., Schiller M.R., Shin D.G., Mayer B.J. High-throughput phosphotyrosine profiling using SH2 domains. Mol. Cell 2007, 26:899-915.
28. Blagoev B., Kratchmarova I., Ong S.E., Nielsen M., Foster L.J., Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 2003, 21:315-318.